Cargando…

P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC ANEMIA

Detalles Bibliográficos
Autores principales: Barcellini, W., Butler, K., Moran, S., Bibeau, K., Dzhindzhikhashvili, I., Wei, S., Jäger, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431322/
http://dx.doi.org/10.1097/01.HS9.0000848988.44172.ff